Biological and structural evaluation of 10R- and 10S-methylthio-DDACTHF reveals a new role for sulfur in inhibition of glycinamide ribonucleotide transformylase.
Biological and structural evaluation of 10R- and 10S-methylthio-DDACTHF reveals a new role for sulfur in inhibition of glycinamide ribonucleotide transformylase.
复制标题
DOI:
10.1021/bi4005182
复制
发表时间:
2013-07-30
期刊:
影响因子:
2.9
通讯作者:
Wilson, Ian A.
中科院分区:
文献类型:
--
作者:
Connelly, Stephen;DeMartino, Jessica K.;Boger, Dale L.;Wilson, Ian A.
Glycinamide ribonucleotide transformylase (GAR Tfase) is a folate-dependent enzyme in the de novo purine biosynthesis pathway, which has long been considered a potential target for development of anti-neoplastic therapeutics. Here we report the biological and X-ray crystallographic evaluations of both independent C10 diastereomers 10S and 10R methylthio-DDACTHF bound to human GAR Tfase, including the highest resolution apo GAR Tfase structure to date (1.52 Å). Both diastereomers are potent inhibitors (10R Ki = 210 nM, 10S Ki = 180 nM) of GAR Tfase and exhibit effective inhibition of human leukemia cell growth (IC50 = 80 and 50 nM, respectively). Their inhibitory activity was surprisingly high and these lipophilic C10-substituted analogs show distinct advantages over their hydrophilic counterparts, most strikingly in retaining potency in mutant human leukemia cell lines that lack reduced folate carrier protein activity (IC50 = 70 and 60 nM, respectively). Structural characterization reveals a new binding mode for these diasterisomers, in which the lipophilic thiomethyl groups penetrate deeper into a hydrophobic pocket within the folate-binding site. In silico docking simulations of three other sulfur-containing folate analogs also indicates that this hydrophobic cleft represents a favorable region for binding lipophilic substituents. Overall, these results suggest sulfur and its substitutions play an important role in not only the binding of anti-folates to GAR Tfase, but also in selectivity and cellular activity (growth inhibition), thereby presenting new possibilities for future design of potent and selective anti-folate drugs that target GAR Tfase.
登录
查看更多内容
DOI:
10.1107/s0907444904019158
发表时间:
2004-12-01
影响因子:
2.2
作者:
Emsley, P;Cowtan, K
通讯作者:
Cowtan, K
影响因子:
3.6
作者:
Chen, ZH;Olopade, OI;Savarese, TM
通讯作者:
Savarese, TM
影响因子:
3.5
作者:
Cheng, H;Hwang, I;Boger, DL
通讯作者:
Boger, DL
影响因子:
3.4
作者:
Boritzki, TJ;Barlett, CA;Jackson, RC
通讯作者:
Jackson, RC
影响因子:
7.3
作者:
BIGHAM, EC;HODSON, SJ;FERONE, R
通讯作者:
FERONE, R